Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Dynacil
2. Fosenopril
3. Fosinil
4. Fosinopril
5. Fosinopril Sodium
6. Fosinopril, (1(s*(r*)),2 Alpha,4 Alpha)-(d-pro)-isomer
7. Fosinopril, (1(s*(r*)),2 Alpha,4 Beta)-isomer
8. Fosinopril, (1(s*(s*)),2 Alpha,4 Beta)-isomer
9. Fosinorm
10. Fositens
11. Fozitec
12. Hiperlex
13. Monopril
14. Newace
15. Sodium, Fosinopril
16. Sq 28,555
17. Sq 28555
18. Sq-28,555
19. Sq-28555
20. Sq28,555
21. Sq28555
22. Staril
23. Tenso Stop
24. Tensocardil
1. Fosinopril Sodium
2. 88889-14-9
3. Chebi:5164
4. 1217528-56-7
5. Dynacil
6. Eliten
7. Sodium;(2s,4s)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
8. Sodium (2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate
9. Fosinopril Sodium- Bio-x
10. Ncgc00167432-01
11. Dsstox_cid_26621
12. Dsstox_rid_81772
13. Dsstox_gsid_46621
14. Schembl40690
15. Chembl3188382
16. Dtxsid7046621
17. Tox21_112436
18. Mfcd00897699
19. Akos015888700
20. Ac-6227
21. Bcp9000703
22. Bs-1003
23. Sq28555
24. Bf164489
25. Cas-88889-14-9
26. A842989
27. Sodium (2s,4s)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate
28. Sodium (2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-
29. Sodium (2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)-(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate
30. Sodium (2s,4s)-4-cyclohexyl-1-(2-{[2-methyl-1-(propionyloxy) Propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate
31. Sodium(2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate
| Molecular Weight | 585.6 g/mol |
|---|---|
| Molecular Formula | C30H45NNaO7P |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 15 |
| Exact Mass | 585.28313405 g/mol |
| Monoisotopic Mass | 585.28313405 g/mol |
| Topological Polar Surface Area | 113 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 857 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Fosinopril sodium |
| Drug Label | Fosinopril sodium tablet, USP is the sodium salt of fosinopril USP, the ester prodrug of an angiotensin converting enzyme (ACE) inhibitor, fosinoprilat. It contains a phosphinate group capable of specific binding to the active site of angiotensin con... |
| Active Ingredient | Fosinopril sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 10mg; 40mg; 20mg |
| Market Status | Prescription |
| Company | Actavis Labs Fl; Teva; Apotex; Aurobindo Pharma; Sandoz; Invagen Pharms |
| 2 of 2 | |
|---|---|
| Drug Name | Fosinopril sodium |
| Drug Label | Fosinopril sodium tablet, USP is the sodium salt of fosinopril USP, the ester prodrug of an angiotensin converting enzyme (ACE) inhibitor, fosinoprilat. It contains a phosphinate group capable of specific binding to the active site of angiotensin con... |
| Active Ingredient | Fosinopril sodium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 10mg; 40mg; 20mg |
| Market Status | Prescription |
| Company | Actavis Labs Fl; Teva; Apotex; Aurobindo Pharma; Sandoz; Invagen Pharms |
Angiotensin-Converting Enzyme Inhibitors
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16008
Submission : 2002-06-11
Status : Active
Type : II
Certificate Number : CEP 2013-018 - Rev 02
Issue Date : 2023-11-29
Type : Chemical
Substance Number : 1751
Status : Valid
Date of Issue : 2025-09-19
Valid Till : 2028-07-03
Written Confirmation Number : WC-0040
Address of the Firm :
NDC Package Code : 65977-0004
Start Marketing Date : 1991-05-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19711
Submission : 2006-08-17
Status : Active
Type : II
Certificate Number : CEP 2010-030 - Rev 02
Issue Date : 2023-12-06
Type : Chemical
Substance Number : 1751
Status : Valid
Date of Issue : 2022-06-06
Valid Till : 2025-06-10
Written Confirmation Number : WC-0017
Address of the Firm :
NDC Package Code : 65862-393
Start Marketing Date : 2023-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-06
Pay. Date : 2012-11-23
DMF Number : 17805
Submission : 2004-10-27
Status : Active
Type : II
Certificate Number : R1-CEP 2011-271 - Rev 01
Issue Date : 2022-01-11
Type : Chemical
Substance Number : 1751
Status : Valid
NDC Package Code : 64220-144
Start Marketing Date : 2008-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15326
Submission : 2001-02-28
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16321
Submission : 2002-12-17
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15934
Submission : 2002-04-11
Status : Inactive
Type : II

Certificate Number : CEP 2021-425 - Rev 00
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 1751
Status : Valid

Certificate Number : CEP 2024-433 - Rev 00
Issue Date : 2025-01-29
Type : Chemical
Substance Number : 1751
Status : Valid


FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15326
Submission : 2001-02-28
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19711
Submission : 2006-08-17
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16008
Submission : 2002-06-11
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15934
Submission : 2002-04-11
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16321
Submission : 2002-12-17
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-02-06
Pay. Date : 2012-11-23
DMF Number : 17805
Submission : 2004-10-27
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2010-030 - Rev 02
Status : Valid
Issue Date : 2023-12-06
Type : Chemical
Substance Number : 1751

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2013-018 - Rev 02
Status : Valid
Issue Date : 2023-11-29
Type : Chemical
Substance Number : 1751

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2021-425 - Rev 00
Status : Valid
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 1751

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Fosinopril Sodium, Rhodium Process
Certificate Number : CEP 2024-433 - Rev 00
Status : Valid
Issue Date : 2025-01-29
Type : Chemical
Substance Number : 1751

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2011-271 - Rev 01
Status : Valid
Issue Date : 2022-01-11
Type : Chemical
Substance Number : 1751

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Date of Issue : 2022-06-06
Valid Till : 2025-06-10
Written Confirmation Number : WC-0017
Address of the Firm : Unit-II, SurveyNo.:10&13,Gaddapotharam (Village), IDA-Kazipally, Jinnaram (Manda...

Date of Issue : 2025-09-19
Valid Till : 2028-07-03
Written Confirmation Number : WC-0040
Address of the Firm : Unit-l, Sy. No. 213, 214 & 255, Bonthapally (Village),Gummadidala (Mandal), Sang...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Amino Chemicals Ltd. manufactures high quality bulk active ingredients to support its customers for the earliest possible launch of generic pharmaceutical products into regulated m...

About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...

About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceu...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
TRANS-4-CYCLOHEXYL-L-PROLINE HCL
CAS Number : 90657-55-9
End Use API : Fosinopril
About The Company : Dasami Lab Private Limited incorporated with MCA on 24 July 2015. The Dasami Lab Private Limited is listed in the class of pvtltd company and classified as Non ...

[(2-methyl-1-propionylpropoxy)(4-phenylbutyl)phosp...
CAS Number : 137590-32-0
End Use API : Fosinopril
About The Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 200...

trans-4-Cyclohexyl-L-proline,hychochloride
CAS Number : 90657-55-9
End Use API : Fosinopril
About The Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 200...

CAS Number : 103201-78-1
End Use API : Fosinopril
About The Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 200...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Fosinopril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosinopril manufacturer or Fosinopril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosinopril manufacturer or Fosinopril supplier.
PharmaCompass also assists you with knowing the Fosinopril API Price utilized in the formulation of products. Fosinopril API Price is not always fixed or binding as the Fosinopril Price is obtained through a variety of data sources. The Fosinopril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fozitec manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fozitec, including repackagers and relabelers. The FDA regulates Fozitec manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fozitec API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fozitec manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fozitec supplier is an individual or a company that provides Fozitec active pharmaceutical ingredient (API) or Fozitec finished formulations upon request. The Fozitec suppliers may include Fozitec API manufacturers, exporters, distributors and traders.
click here to find a list of Fozitec suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fozitec DMF (Drug Master File) is a document detailing the whole manufacturing process of Fozitec active pharmaceutical ingredient (API) in detail. Different forms of Fozitec DMFs exist exist since differing nations have different regulations, such as Fozitec USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fozitec DMF submitted to regulatory agencies in the US is known as a USDMF. Fozitec USDMF includes data on Fozitec's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fozitec USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fozitec suppliers with USDMF on PharmaCompass.
A Fozitec CEP of the European Pharmacopoeia monograph is often referred to as a Fozitec Certificate of Suitability (COS). The purpose of a Fozitec CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fozitec EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fozitec to their clients by showing that a Fozitec CEP has been issued for it. The manufacturer submits a Fozitec CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fozitec CEP holder for the record. Additionally, the data presented in the Fozitec CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fozitec DMF.
A Fozitec CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fozitec CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fozitec suppliers with CEP (COS) on PharmaCompass.
A Fozitec written confirmation (Fozitec WC) is an official document issued by a regulatory agency to a Fozitec manufacturer, verifying that the manufacturing facility of a Fozitec active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fozitec APIs or Fozitec finished pharmaceutical products to another nation, regulatory agencies frequently require a Fozitec WC (written confirmation) as part of the regulatory process.
click here to find a list of Fozitec suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fozitec as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fozitec API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fozitec as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fozitec and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fozitec NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fozitec suppliers with NDC on PharmaCompass.
Fozitec Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fozitec GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fozitec GMP manufacturer or Fozitec GMP API supplier for your needs.
A Fozitec CoA (Certificate of Analysis) is a formal document that attests to Fozitec's compliance with Fozitec specifications and serves as a tool for batch-level quality control.
Fozitec CoA mostly includes findings from lab analyses of a specific batch. For each Fozitec CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fozitec may be tested according to a variety of international standards, such as European Pharmacopoeia (Fozitec EP), Fozitec JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fozitec USP).